BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2924411)

  • 1. Epinephrine-induced reversal of verapamil's electrophysiologic and therapeutic effects in patients with paroxysmal supraventricular tachycardia.
    Morady F; Kou WH; Kadish AH; Toivonen LK; Kushner JA; Schmaltz S
    Circulation; 1989 Apr; 79(4):783-90. PubMed ID: 2924411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M; Yasuda H; Kato N; Nomura A; Fujita M; Nishino T; Fujita K; Koike Y; Saito H
    Am Heart J; 1983 Apr; 105(4):619-28. PubMed ID: 6837416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradoxical adverse effect of verapamil for treating clinical paroxysmal supraventricular tachycardia.
    Saikawa T; Inoue K; Ohmura I; Ito S; Yonemochi H; Nakagawa M; Ito M; Ohashi K; Ebihara A
    Jpn Heart J; 1987 Jan; 28(1):107-13. PubMed ID: 3599396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
    Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
    Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia].
    Tsuchioka Y; Nakagawa H; Yamagata T; Sakura E; Hashimoto M; Okamoto M; Matsuura H; Kajiyama G
    Kokyu To Junkan; 1990 Mar; 38(3):243-8. PubMed ID: 2109870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP; Miles W; Akhtar M; Milstein S; Sharma AD; Platia E; McGovern B; Scheinman MM; Govier WC
    Ann Intern Med; 1990 Jul; 113(2):104-10. PubMed ID: 2193560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of paroxysmal supraventricular tachycardia with adenosine: implications for nursing.
    Severson AL; Meyer LT
    Heart Lung; 1992; 21(4):350-6. PubMed ID: 1629004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia.
    Bauernfeind RA; Wyndham CR; Dhingra RC; Swiryn SP; Palileo E; Strasberg B; Rosen KM
    Circulation; 1980 Dec; 62(6):1341-9. PubMed ID: 7438370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of antiarrhythmic drugs of class 1C and isoptin in paroxysmal supraventricular tachycardia].
    Koshumbaeva KM; Tulenov MT; Belokopit IN
    Klin Med (Mosk); 2002; 80(2):57-60. PubMed ID: 11898726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P; Bernabò D; Faraguti SA
    Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS; Bhargava M; Arora R; Khalilullah M
    Indian Heart J; 1995; 47(3):237-43. PubMed ID: 7558090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B; Glick A; Laniado S
    Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias].
    Luciardi H; Berman S; Santana M; Monteros L
    Arch Inst Cardiol Mex; 1996; 66(6):505-9. PubMed ID: 9133311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
    Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
    J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).
    Stambler BS; Plat F; Sager PT; Shardonofsky S; Wight D; Potvin D; Pandey AS; Ip JE; Coutu B; Mondésert B; Sterns LD; Bennett M; Anderson JL; Damle R; Haberman R; Camm AJ
    Circ Arrhythm Electrophysiol; 2022 Dec; 15(12):e010915. PubMed ID: 36441560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia].
    Cheng KA;
    Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):773-6. PubMed ID: 14636464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
    Bhandari AK; Anderson JL; Gilbert EM; Alpert BL; Henthorn RW; Waldo AL; Cullen MT; Hawkinson RW; Pritchett EL
    Am Heart J; 1992 Aug; 124(2):381-6. PubMed ID: 1636582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.